ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 888 filers reported holding ISHARES TR in Q1 2024. The put-call ratio across all filers is 4.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,514,134 | +14.6% | 76,600 | +14.5% | 1.89% | +14.8% |
| Q1 2024 | $9,176,057 | +2.1% | 66,871 | +1.6% | 1.64% | -2.5% |
| Q4 2023 | $8,987,101 | +17.5% | 65,830 | +5.2% | 1.69% | +9.3% |
| Q3 2023 | $7,651,697 | -5.6% | 62,570 | +1.5% | 1.54% | -0.5% |
| Q2 2023 | $8,103,429 | +6.9% | 61,637 | +5.1% | 1.55% | -1.1% |
| Q1 2023 | $7,577,441 | +15.0% | 58,667 | +16.9% | 1.57% | +10.0% |
| Q4 2022 | $6,588,001 | -5.3% | 50,179 | -15.7% | 1.43% | -8.8% |
| Q3 2022 | $6,959,000 | +2.2% | 59,502 | +2.8% | 1.56% | +4.1% |
| Q2 2022 | $6,811,000 | -9.8% | 57,903 | -0.1% | 1.50% | +2.1% |
| Q1 2022 | $7,552,000 | +193.3% | 57,959 | +243.5% | 1.47% | +196.4% |
| Q4 2021 | $2,575,000 | +14.9% | 16,871 | +21.7% | 0.50% | +10.2% |
| Q3 2021 | $2,241,000 | -13.7% | 13,862 | -12.7% | 0.45% | -9.5% |
| Q2 2021 | $2,598,000 | +10.1% | 15,878 | +1.3% | 0.50% | +1.0% |
| Q1 2021 | $2,359,000 | -5.8% | 15,668 | -5.2% | 0.49% | -5.7% |
| Q4 2020 | $2,504,000 | – | 16,526 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |